Evidence map›Paper›PMID 24308533›Full record

ReviewChemical reviews2014

Retinoic acid actions through mammalian nuclear receptors.

Pengxiang Huang, Vikas Chandra, Fraydoon Rastinejad

Abstract readReview
In one paragraph

Review in Chemical reviews, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Lipid droplets as cell fate determinants in skeletal muscle.Trends in endocrinology and metabolism: TEM · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Cancer prevention: past challenges and future directions.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2025
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Pet Wellness and Vitamin A: A Narrative Overview.Animals : an open access journal from MDPI · 2024
    Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pengxiang HuangMetabolic Signaling and Disease Program, Sanford-Burnham Medical Research Institute , Orlando, Florida 32827, United States.
Vikas Chandra
Fraydoon Rastinejad

Funding

Identification of Allsoteric Ligands for Hepatic Nuclear Factor 4-alphaR01DK097475 · NIDDK · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RASTINEJAD, FRAYDOON · 2013 to 2015
$1.8M
Identification of Rev-Erb alpha/beta nuclear receptor modulatorsR01DK101520 · NIDDK · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RASTINEJAD, FRAYDOON · 2014 to 2016
$1.7M
Structural Characterization of Metabolic Gene RegulatorsR01DK094147 · NIDDK · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RASTINEJAD, FRAYDOON · 2011 to 2014
$1.7M
NIDDK NIH HHS R01 DK094147NIDDK NIH HHS R01 DK097475NIDDK NIH HHS R01 DK101520
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsDNAMetabolic DiseasesNeoplasmsReceptors, Cytoplasmic and NuclearReceptors, Retinoic AcidRetinoid X ReceptorsSignal TransductionSkin DiseasesTretinoinDNAReceptors, Cytoplasmic and NuclearReceptors, Retinoic AcidRetinoid X ReceptorsTretinoin

Identifiers

PMID24308533
PMCPMC3931982

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.